Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care [Perspectives]

Abstract

SUMMARY Treatment outcomes for multidrug-resistant tuberculosis (MDR-TB) in South Africa have suffered as centralized, inpatient treatment programs struggle to cope with rising prevalence and HIV co-infection rates. A new treatment model is needed to expand treatment capacity and improve MDR-TB and HIV outcomes. We describe the design and preliminary results of an integrated, home-based MDR-TB/HIV treatment program created in rural KwaZulu-Natal. In 2008, a decentralized center was established to provide outpatient MDR-TB and HIV treatment. Nurses, community health workers, and family supporters have been trained to administer injections, provide adherence support, and monitor adverse reactions in patients’ homes. Physicians assess clinical response, adherence, and adverse reaction severity to MDR-TB and HIV therapy at monthly follow-up visits. Treatment outcomes are assessed by monthly cultures and CD4 and viral load every 6 months. Eighty patients initiated MDR-TB therapy from 2/2008–4/2010; 66 were HIV co-infected. Retention has been high (only 5% defaults, 93% of visits attended) and preliminary outcomes have been favorable (77% cured/still on treatment, 82% undetectable viral load). Few patients have required escalation of care (9%), had severe adverse events (8%), or died (6%). Integrated, home-based treatment for MDR-TB and HIV is a promising treatment model to expand capacity and achieve improved outcomes in rural, resource-poor, and high-HIV prevalent settings.

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

“…Decentralisation improves access to treatment without compromising treatment outcomes and is cost effective. [511][512][513][514][515] Successful decentralisation requires relatively robust health-care infrastructure. 516 …”

Risk factors for unfavourable treatment outcome among new smear-positive pulmonary tuberculosis cases in China

“…5,17 Where the information was available, the majority of the patients had been assigned a DOT provider, and most of them were managed by medical staff (mainly rural doctors). A study in China revealed that DOT provided by family members led to less frequent interruption in the treatment of MDR-TB than among patients whose treatment was supported by village doctors.…”

Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers

“…High levels of care for drug-resistant TB or among HIV coinfected patients do not necessarily need to be hospitalized [12]. Demands for treatment programs include quality-assured drugs, regimens being based on an adequate number, and the selection of effective drugs given for an appropriate duration [13].…”